Implementation of high dose rate brachytherapy in limited resource settings
Brachytherapy is an essential component of the curative treatment of cervical cancer, a disease with high incidence in many developing countries The IAEA supports the use of high dose rate brachytherapy for centres with a large number of patients with this disease. HDR brachytherapy is also used in...
Guardado en:
Otros Autores: | |
---|---|
Formato: | Sin ejemplares |
Lenguaje: | Inglés |
Publicado: |
Vienna :
IAEA,
2015.
|
Colección: | IAEA Human Health Series ;
no. 30, |
Materias: | |
Acceso en línea: | Texto completo Tapa |
LEADER | 02089nam#a22003615a#4500 | ||
---|---|---|---|
001 | BCCAB018087 | ||
008 | 150820s2015####au#a###fsb####001#0#eng#d | ||
005 | 20151112104443.0 | ||
003 | AR-BCCAB | ||
245 | 0 | 0 | |a Implementation of high dose rate brachytherapy in limited resource settings |h [recurso electrónico] / |c International Atomic Energy Agency. |
260 | # | # | |a Vienna : |b IAEA, |c 2015. |
300 | # | # | |a 97 p. : |b il. (algunas col.), tablas ; |c 24 cm. |
490 | 0 | # | |a IAEA Human Health Series ; |v no. 30, |x 20753772 |
500 | # | # | |a STI/PUB/1670. |
500 | # | # | |a Título tomado de la versión electrónica (consultado: 20.08.15). |
504 | # | # | |a Includes bibliographical references. |
520 | # | # | |a Brachytherapy is an essential component of the curative treatment of cervical cancer, a disease with high incidence in many developing countries The IAEA supports the use of high dose rate brachytherapy for centres with a large number of patients with this disease. HDR brachytherapy is also used in other common cancers such as breast cancer, lung, oesophagus and prostate. This publication provides guidance to radiation oncologists, medical physicists and planners on establishing and operating a high dose rate brachytherapy unit with modern standards and presents the main issues to be addressed for its effective and safe operation. |
538 | # | # | |a Modo de acceso: World Wide Web. |
020 | # | # | |a 9789201072146 |
710 | 2 | # | |a International Atomic Energy Agency. |
080 | # | # | |a 615.849 |
650 | # | 7 | |a Radioisotope brachytherapy |2 inist |
650 | # | 7 | |a Cancer - Radiotherapy |2 inist |
650 | # | 7 | |a Radiotherapy - Safety measures |2 inist |
650 | # | 7 | |a Brachytherapy |2 inist |
650 | # | 7 | |a Radisotopos |2 inist |
650 | # | 7 | |a Radioterapia |2 inist |
650 | # | 7 | |a Braquiterapia |2 inist |
040 | # | # | |a arbccab |b spa |
856 | 4 | 0 | |q pdf |s 1.784 Kb |u http://www-pub.iaea.org/MTCD/Publications/PDF/Pub1670web-5444797.pdf |3 Texto completo |
856 | 4 | 0 | |u http://campi.cab.cnea.gov.ar/tocs/tapas/p1670cov-40576868.jpg |3 Tapa |
942 | # | # | |c BK |
952 | # | # | |2 udc |7 NOT_LOAN |a ARBCCAB |b ARBCCAB |i 018087_nuevo-0 |o Acceso Web |p 018087_nuevo-0 |t 1 |y VM |